Application of protein deacetylase inhibitor 3-TYP in ultralow-temperature cryopreservation of poultry semen

By using the protein deacetylase inhibitor 3-TYP in ultra-low cryopreservation of chicken semen, the deacetylation modification of sperm cells was inhibited, and the problem of poor anti-freeze ability of chicken semen was solved, and the fertilization ability of frozen-rethawed sperm was significantly improved.

CN119867055AActive Publication Date: 2025-04-25INSTITUTE OF ANIMAL SCIENCES OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Patent Information

Application Number
CN202411849524.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-12-16
Publication Date
2025-04-25
Estimated Expiration
2044-12-16

AI Technical Summary

Technical Problem

The prior art has the problem of poor anti-freeze ability in the ultra-low-temperature cryopreservation of chicken semen, and lacks research on the protection and damage repair mechanism of sperm to cope with low temperature stimulation.

Method used

The protein deacetylation enzyme inhibitor 3-TYP is used as an active ingredient and added to the semen frozen dilution and cryoprotective solution to inhibit the deacetylation modification of sperm cells and maintain a high level of acetylation modification level, thereby improving the antifreeze ability of sperm.

Benefits of technology

By inhibiting the activity of the acetylation enzyme SIRT5, maintaining high levels of acetylation modification, improving the ability of poultry sperm to respond to ultra-low-temperature cryogenic stimulation, and improving the fertilization ability of frozen-rethawed sperm.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119867055A_ABST
    Figure CN119867055A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of poultry breed conservation biology, and discloses application of a protein deacetylase inhibitor 3-TYP in ultralow-temperature cryopreservation of poultry seminal fluid. Tests prove that the protein deacetylase inhibitor 3-TYP can improve the acetylation modification level of poultry sperms and improve the fertilization capacity of frozen-remelted poultry sperms; therefore, the protein deacetylase inhibitor 3-TYP can be used as an effective component for ultralow-temperature cryopreservation of poultry seminal fluid, and plays an important role in improving the ultralow-temperature cryopreservation efficiency of poultry.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of poultry seed preservation biotechnology, and in particular to application of a protein deacetylase inhibitor 3-TYP in ultra-low temperature cryopreservation of poultry semen. Background Art

[0002] Semen ultra-low temperature cryopreservation technology is a method of placing sperm under ultra-low temperature conditions such as liquid nitrogen (-196℃) to inhibit sperm metabolism and achieve long-term storage of sperm for subsequent use. Ultra-low temperature cryopreserved semen can restore its fertilization ability after thawing and warming. Therefore, semen ultra-low temperature cryopreservation technology is of great significance in livestock and poultry conservation and breeding. Semen ultra-low temperature cryopreservation technology can also be applied to the construction of sperm banks, which can effectively preserve the genetic information of species, prevent the loss of genetic information due to environmental and selection factors, maintain the genetic diversity of species, and reduce the risk of species extinction. It is an important means of livestock and poultry translocation conservation; in addition, semen ultra-low temperature cryopreservation technology can break through the limitations of time and space, realize the exchange of genetic resources of different generations and regions, and promote livestock and poultry genetic improvement and the cultivation of new varieties.

[0003] The world has abundant chicken genetic resources, which are a valuable asset for the livestock industry. When ultra-low temperature freezing and preservation of chicken semen, the chicken sperm has a small head and a long tail, which leads to poor antifreeze ability. Therefore, establishing a stable and efficient chicken semen freezing and preservation technology has always been a hot spot and difficulty in research in this field. Existing theoretical research on chicken semen freezing and preservation mainly focuses on reducing sperm structural damage caused by ice crystallization and inhibiting sperm chemical damage caused by oxidative stress, but lacks research on the protection and damage repair mechanism of sperm in response to low temperature stimulation. The transcription and translation of mature sperm are stagnant, and protein post-translational modification is an important way for mature sperm to respond to internal and external environmental stimuli, and may play an important role in maintaining sperm structural integrity, mitochondrial functional integrity and DNA structural integrity. Based on this, a poultry semen cryoprotectant based on protein post-translational modification is provided, which can promote the further development of semen ultra-low temperature freezing and preservation technology. Summary of the invention

[0004] The purpose of the present invention is to provide an application of a protein deacetylase inhibitor 3-TYP in ultra-low temperature cryopreservation of poultry semen. The protein deacetylase inhibitor 3-TYP is used as an effective ingredient for ultra-low temperature cryopreservation of poultry semen, which plays an important role in improving the ultra-low temperature cryopreservation efficiency of poultry.

[0005] To achieve the above object, the present invention provides the following technical solutions:

[0006] Application of protein deacetylase inhibitor 3-TYP in ultra-low temperature cryopreservation of poultry semen.

[0007] The protein deacetylase inhibitor 3-TYP provided by the present invention has a structural formula as follows:

[0008]

[0009] Furthermore, the application of the protein deacetylase inhibitor 3-TYP in ultra-low temperature cryopreservation of poultry semen is specifically as follows: adding the protein deacetylase inhibitor 3-TYP to semen freezing diluent and semen cryoprotectant at an osmotic pressure of 360mOsm / kg.

[0010] Furthermore, the protein deacetylase inhibitor 3-TYP can be used in combination with other cryoprotectant agents.

[0011] Compared with the prior art, the present invention has the following beneficial effects:

[0012] The application of the protein deacetylase inhibitor 3-TYP provided by the present invention in ultra-low temperature cryopreservation of poultry semen has been proved by experiments that the acetylation modification of lysine in poultry sperm protein is involved in the freezing stimulation response of poultry sperm, and the protein deacetylase inhibitor 3-TYP can inhibit the deacetylation modification of poultry sperm cells (specifically inhibiting the acetylase NAD + The activity of SIRT5 of the SIRT-dependent family) is activated by 3-TYP to maintain a high level of acetylation modification, thereby improving the ability of poultry sperm to respond to ultra-low temperature freezing stimulation and the fertilization ability of poultry frozen-rethawed sperm; therefore, the protein deacetylase inhibitor 3-TYP can be used as an effective ingredient for ultra-low temperature cryopreservation of poultry semen, which plays an important role in improving the efficiency of ultra-low temperature cryopreservation of poultry. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Various other advantages and benefits will become apparent to those of ordinary skill in the art by reading the detailed description of the preferred embodiments below. The accompanying drawings are only for the purpose of illustrating the preferred embodiments and are not to be considered as limiting the present invention. Moreover, the same reference symbols are used throughout the accompanying drawings to represent the same components. In the accompanying drawings:

[0014] Figure 1 This is the result of the test of sperm protein acetylation modification level in the high-freeze resistance rooster group and the low-freeze resistance rooster group;

[0015] Figure 2 The results of the test of sperm protein acetylation modification level in blank control group, TSA control group and 3-TYP group are shown in the figure;

[0016] Figure 3 This is a graph showing the fertilization rate test results for the blank control group, TSA control group and 3-TYP group. DETAILED DESCRIPTION

[0017] Now, various exemplary embodiments of the present invention are described in detail, and this detailed description should not be considered as a limitation of the present invention, but should be understood as a more detailed description of certain aspects, characteristics and embodiments of the present invention. It should be understood that the terms described in the present invention are only for describing specific embodiments and are not used to limit the present invention.

[0018] In addition, for the numerical range in the present invention, it is understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. Each smaller range between the intermediate value in any stated value or stated range and any other stated value or intermediate value in the range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.

[0019] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.

[0020] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.

[0021] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.

[0022] In the present invention, unless otherwise specified, the semen freezing diluent, semen cryoprotectant and thawing solution used are the same as those in "Interspecific differences in chicken sperm antifreeze and their correlation with seminal plasma biochemical indices and candidate gene expression" Zong Yunhe et al., China Poultry, 2020: 42(12): 6-13. The protein lysis solution used contains 8M urea, 1% TritonX-100, 10mM dithiothreitol and 1% protease inhibitor mixture.

[0023] 1. Acetylation level of poultry sperm and sperm antifreeze ability

[0024] 1. Sample collection

[0025] According to the "Test Method for Quality of Poultry Semen (NY / T 4047-2021)", sperm motility higher than 60%, semen volume higher than 350 μL, and density higher than 16×10 8 55 healthy adult Beijing oily chickens with a concentration of 100 g / mL were selected, and semen was collected by dorsal and abdominal massage.

[0026] 2. Semen dilution, balancing and freezing

[0027] 200 μL of fresh semen was taken and mixed with 200 μL of semen cryoprotectant preheated to 37°C, and then equilibrated at 4°C for 30 min. Then 400 μL of 4°C semen cryoprotectant was added and divided into semen tubes. After the tubes were sealed, they were placed in a programmed freezer for cooling and freezing. The freezing program was set to 4°C to -44°C at a rate of 12°C / min; -44°C to -120°C at a rate of 40°C / min, and then stored in liquid nitrogen.

[0028] 3. Thawing and sperm motility test

[0029] Take out the semen tube from liquid nitrogen, immerse it in 4℃ water to thaw for 3 minutes, pour it into a centrifuge tube, measure the volume and add 2 times the volume of 4℃ thawing solution to obtain a frozen-rethawed sperm sample;

[0030] The computer-assisted sperm analysis system was used to detect the sperm motility in the frozen-thawed sperm samples, and the change in sperm motility before and after freezing was used as an indicator of sperm antifreeze ability.

[0031] Sperm motility change range = fresh sperm motility - frozen-thawed sperm motility

[0032] After 4 tests, 5 high-freeze-resistance roosters and 5 low-freeze-resistance roosters with stable traits were selected for subsequent experiments. The changes in sperm motility in the high-freeze-resistance rooster group and the low-freeze-resistance rooster group are shown in Table 1;

[0033] Table 1 Variation of sperm motility in high-freeze-resistant rooster group and low-freeze-resistant rooster group

[0034]

[0035] 4. Extraction of sperm protein

[0036] Semen from high-antifreeze rooster group and low-antifreeze rooster group were collected respectively, centrifuged at 4°C and 12000g for 10 min to remove seminal plasma, washed twice with PBS, then added with 4 times volume of protein lysis buffer, ultrasonically lysed, centrifuged at 4°C and 12000g for 10 min to remove cell debris, and the supernatant was transferred to a new centrifuge tube to obtain sperm protein samples from high-antifreeze rooster group and low-antifreeze rooster group; protein concentration was detected using BCA kit;

[0037] 5. Detection of sperm protein acetylation modification level

[0038] 13 μg of sperm protein samples from high antifreeze rooster group and low antifreeze rooster group were taken respectively. After electrophoresis, membrane transfer and blocking, protein acetylation pan-antibody (Ant i-acety l lys i ne Antibody, PTM-101, 12838533L303) was added for primary antibody incubation. After the primary antibody incubation, secondary antibody incubation (Goat anti-Mouse IgG (H+L), Peroxidase Conjugated, 31430) was performed. After the secondary antibody incubation, the samples were rinsed and incubated with chemiluminescent HRP substrate for 2 minutes. Signal capture was performed according to the operating instructions of the chemiluminescent imaging system.

[0039] 6. Experimental results

[0040] The results of sperm protein acetylation modification in the high and low frost resistance rooster groups are as follows Figure 1 As shown, samples 1 to 5 are sperm samples from the high-freeze-resistance rooster group, and samples 6 to 10 are sperm samples from the low-freeze-resistance rooster group;

[0041] Depend on Figure 1 It can be seen that there are certain differences in the acetylation modification levels of sperm proteins in the high-freeze resistance rooster group and the low-freeze resistance rooster group. Among them, the acetylation modification level of protein near 35kD in the low-freeze resistance rooster group is higher, while the acetylation modification level of protein near 30kD is relatively low, which indicates that the acetylation modification level of poultry sperm is related to the antifreeze ability of sperm.

[0042] 2. Analysis of deacetylases involved in sperm protein acetylation

[0043] 1. Sample collection and protein extraction

[0044] Six adult healthy Beijing oily roosters were randomly selected, and semen was collected by dorsal and abdominal massage method, and centrifuged at 4℃ and 5000g for 10min; the supernatant was aspirated and transferred to a new centrifuge tube, centrifuged at 4℃ and 12000g for 10min, and 2 volumes of protein lysis buffer were added to obtain a seminal plasma protein sample; the precipitate was added to PBS for resuspending, centrifuged and washed, 4 volumes of protein lysis buffer were added, ultrasonic lysis was performed, and cell debris was removed by centrifugation at 4℃ and 12000g for 10min, and the supernatant was transferred to a new centrifuge tube to obtain a sperm protein sample; the roosters were slaughtered, the testicular tissue was separated, and a soybean-sized testicular sample was taken, 4 volumes of lysis buffer were added, homogenized and lysed, and centrifuged at 4℃ and 12000g for 10min to remove cell debris, and the supernatant was transferred to a new centrifuge tube to obtain a testicular protein sample;

[0045] The protein concentration of sperm protein samples, testicular protein samples and seminal plasma protein samples was tested using the BCA kit;

[0046] 2. Qualitative and quantitative analysis of proteins

[0047] The sperm protein samples, testicular protein samples and seminal plasma protein samples were analyzed by liquid phase tandem mass spectrometry respectively, and the expression profiles of sperm protein, testicular protein and seminal plasma protein were obtained by library search analysis;

[0048] 3. Experimental results

[0049] The deacetylases in sperm protein samples, testis protein samples, and seminal plasma protein samples are shown in Table 2 ;

[0050] Table 2 Deacetylases in sperm protein, testis protein and seminal plasma protein

[0051]

[0052] From the data in Table 2, we can see that both sperm and testis proteins express high abundance of deacetylases, including Zn 2+ NAD+-dependent histone deacetylase family and NAD+-dependent SI RT family.

[0053] 3. Effect of deacetylase inhibitors on the acetylation level of poultry sperm

[0054] 1. Screening of protein deacetylase inhibitors

[0055] Through database search, Zn 2+ TSA (C-dependent histone deacetylase family general inhibitor 17 H 22 N2O3), SIRT3-specific inhibitor 3-TYP (C7H6N4);

[0056] 2. Semen collection and grouping

[0057] According to the "Test Method for Quality of Poultry Semen (NY / T 4047-2021)", sperm motility higher than 60%, semen volume higher than 350 μL, and density higher than 16×10 8 30 adult healthy Beijing oil chickens with a concentration of 100 g / mL were used to collect semen by dorsal and abdominal massage. The semen of each individual was mixed and divided into three groups, namely blank control group, TSA control group and 3-TYP group.

[0058] 3. Preparation of test samples

[0059] According to the osmotic pressure of 360mOsm / kg, sodium chloride (NaCl) was added to the semen freezing diluent to obtain a semen freezing diluent with NaCl as the blank control group;

[0060] Sodium chloride (NaCl) was added to the semen cryoprotective solution at an osmotic pressure of 360 mOsm / kg to obtain a semen cryoprotective solution with NaCl as a blank control group;

[0061] According to the osmotic pressure of 360mOsm / kg, the deacetylase inhibitor TSA is added to the semen freezing diluent to obtain the semen freezing diluent added with the deacetylase inhibitor TSA;

[0062] According to the osmotic pressure of 360mOsm / kg, the deacetylase inhibitor TSA is added to the semen cryoprotective solution to obtain the semen cryoprotective solution added with the deacetylase inhibitor TSA;

[0063] According to the osmotic pressure of 360mOsm / kg, the deacetylase inhibitor 3-TYP is added to the semen freezing diluent to obtain the semen freezing diluent added with the deacetylase inhibitor 3-TYP;

[0064] According to the osmotic pressure of 360mOsm / kg, the deacetylase inhibitor 3-TYP is added to the semen cryoprotective solution to obtain the semen cryoprotective solution added with the deacetylase inhibitor 3-TYP;

[0065] 4. Semen dilution, balancing and freezing

[0066] Blank control group: 200 μL fresh semen was taken and mixed with an equal amount of semen cryoprotectant preheated to 37°C and added with NaCl, and then balanced at 4°C for 30 min. Then 400 μL of 4°C semen cryoprotectant added with NaCl was added, and the semen was divided into semen tubes. After the tubes were sealed, they were placed in a programmed freezer for cooling and freezing. The freezing program was set to 4°C to -44°C, at a rate of 12°C / min; -44°C to -120°C, at a rate of 40°C / min, and then stored in liquid nitrogen;

[0067] TSA control group: 200 μL fresh semen was drawn and mixed with an equal amount of semen cryoprotectant preheated to 37°C and added with the deacetylase inhibitor TSA, and then equilibrated at 4°C for 30 min. Then 400 μL of 4°C semen cryoprotectant added with the deacetylase inhibitor TSA was added, and the mixture was divided into semen tubes. After the tubes were sealed, they were placed in a programmed freezer for cooling and freezing. The freezing program was set to 4°C to -44°C, at a rate of 12°C / min; -44°C to -120°C, at a rate of 40°C / min, and then stored in liquid nitrogen;

[0068] 3-TYP group: 200 μL fresh semen was drawn and mixed with an equal amount of semen cryoprotectant preheated to 37°C and supplemented with the deacetylase inhibitor 3-TYP, and then equilibrated at 4°C for 30 min. Then 400 μL of 4°C semen cryoprotectant supplemented with the deacetylase inhibitor 3-TYP was added and divided into semen tubes. After the tubes were sealed, they were placed in a programmed freezer for cooling and freezing. The freezing program was set to 4°C to -44°C at a rate of 12°C / min; -44°C to -120°C at a rate of 40°C / min, and then stored in liquid nitrogen;

[0069] 5. Thawing

[0070] Semen tubes of the blank control group, TSA control group and 3-TYP group were taken out from liquid nitrogen, immersed in 4°C water for 3 min, poured into centrifuge tubes, and after measuring the volume, 2 times the volume of 4°C thawing solution was added to obtain sperm samples of the blank control group, sperm samples of the TSA control group and sperm samples of the 3-TYP group;

[0071] 6. Extraction of sperm protein

[0072] Four times the volume of lysis buffer was added to the blank control group sperm samples, TSA control group sperm samples and 3-TYP group sperm samples, respectively, ultrasonic lysis was performed, centrifuged at 4°C and 12000g for 10 min, cell debris was removed, and the supernatant was transferred to a centrifuge tube to obtain the blank control group sperm protein sample, TSA control group sperm protein sample and 3-TYP group sperm protein sample;

[0073] 7. Detection of sperm protein acetylation modification level

[0074] 13 μg of sperm protein samples of blank control group, TSA control group and 3-TYP group were taken respectively, after electrophoresis, membrane transfer and blocking, protein acetylation pan-antibody (Anti-acety l lysineAnti body, PTM-101, 12838533L303) was added for primary antibody incubation, and secondary antibody incubation (Goat ai-Mouse IgG (H+L), Peroxidase Conjugated, 31430) was carried out after the primary antibody incubation. After the secondary antibody incubation, the samples were rinsed, and chemiluminescent HRP substrate was added for incubation for 2 minutes, and the signal was captured according to the operating instructions of the chemiluminescent imaging system;

[0075] 8. Test results

[0076] The results of sperm protein acetylation modification in the blank control group, TSA control group and 3-TYP group are as follows Figure 2As shown, A is the sperm protein acetylation modification level map, and B is the gray value of the protein acetylation modification level;

[0077] Depend on Figure 2 It can be seen that the acetylation modification level of sperm protein in the TSA control group and 3-TYP group was higher than that in the blank control group.

[0078] 4. Effect of Sirtuin Inhibitors on the Fertilization Capacity of Poultry Reconstituted Sperm

[0079] 1. Semen collection and grouping

[0080] According to the "Test Method for Quality of Poultry Semen (NY / T 4047-2021)", sperm motility higher than 60%, semen volume higher than 350 μL, and density higher than 16×10 8 30 adult healthy Beijing oil chickens with a concentration of 100 g / mL were used to collect semen by dorsal and abdominal massage. The semen of each individual was mixed and divided into three groups, namely blank control group, TSA control group and 3-TYP group.

[0081] 2. Preparation of test samples

[0082] According to the osmotic pressure of 360mOsm / kg, sodium chloride (NaCl) was added to the semen freezing diluent to obtain a semen freezing diluent with NaCl as the blank control group;

[0083] Sodium chloride (NaCl) was added to the semen cryoprotective solution at an osmotic pressure of 360 mOsm / kg to obtain a semen cryoprotective solution with NaCl as a blank control group;

[0084] According to the osmotic pressure of 360mOsm / kg, the deacetylase inhibitor TSA is added to the semen freezing diluent to obtain the semen freezing diluent added with the deacetylase inhibitor TSA;

[0085] According to the osmotic pressure of 360mOsm / kg, the deacetylase inhibitor TSA is added to the semen cryoprotective solution to obtain the semen cryoprotective solution added with the deacetylase inhibitor TSA;

[0086] According to the osmotic pressure of 360mOsm / kg, the deacetylase inhibitor 3-TYP is added to the semen freezing diluent to obtain the semen freezing diluent added with the deacetylase inhibitor 3-TYP;

[0087] According to the osmotic pressure of 360mOsm / kg, the deacetylase inhibitor 3-TYP is added to the semen cryoprotective solution to obtain the semen cryoprotective solution added with the deacetylase inhibitor 3-TYP;

[0088] 3. Semen dilution, balancing and freezing

[0089] Blank control group: 200 μL fresh semen was taken and mixed with an equal amount of semen cryoprotectant preheated to 37°C and added with NaCl, and then balanced at 4°C for 30 min. Then 400 μL of 4°C semen cryoprotectant added with NaCl was added, and the semen was divided into semen tubes. After the tubes were sealed, they were placed in a programmed freezer for cooling and freezing. The freezing program was set to 4°C to -44°C, at a rate of 12°C / min; -44°C to -120°C, at a rate of 40°C / min, and then stored in liquid nitrogen;

[0090] TSA control group: 200 μL fresh semen was drawn and mixed with an equal amount of semen cryoprotectant preheated to 37°C and added with the deacetylase inhibitor TSA, and then equilibrated at 4°C for 30 min. Then 400 μL of 4°C semen cryoprotectant added with the deacetylase inhibitor TSA was added, and the mixture was divided into semen tubes. After the tubes were sealed, they were placed in a programmed freezer for cooling and freezing. The freezing program was set to 4°C to -44°C, at a rate of 12°C / min; -44°C to -120°C, at a rate of 40°C / min, and then stored in liquid nitrogen;

[0091] 3-TYP group: 200 μL fresh semen was drawn and mixed with an equal amount of semen cryoprotectant preheated to 37°C and supplemented with the deacetylase inhibitor 3-TYP, and then equilibrated at 4°C for 30 min. Then 400 μL of 4°C semen cryoprotectant supplemented with the deacetylase inhibitor 3-TYP was added and divided into semen tubes. After the tubes were sealed, they were placed in a programmed freezer for cooling and freezing. The freezing program was set to 4°C to -44°C at a rate of 12°C / min; -44°C to -120°C at a rate of 40°C / min, and then stored in liquid nitrogen;

[0092] 4. Thawing and removing glycerol

[0093] Semen tubes of the blank control group, TSA control group and 3-TYP group were taken out from liquid nitrogen, immersed in 4°C water for 3 min, poured into centrifuge tubes, and 2 times the volume of 4°C thawing solution was added after measuring the volume, followed by centrifugation at 4°C and 600g for 8-10 min, and the supernatant was removed to obtain sperm pellets of the blank control group, sperm pellets of the TSA control group and sperm pellets of the 3-TYP group;

[0094] 5. Fertilization rate detection

[0095] The same volume of 4℃ DMEM as that of thawed semen was added to the sperm sediments of the blank control group, the TSA control group and the 3-TYP group to resuspend the sediments. 60 healthy Beijing oil chicken hens were selected and randomly divided into 3 groups. The blank control group, the TSA control group and the 3-TYP group were infused with frozen-rethawed sperm, respectively. The insemination volume of each hen was about 100 million sperms. The insemination was continued for 2 days, and the breeding eggs were collected for 4 days, incubated and the fertilization rate was calculated.

[0096] 6 Experimental results

[0097] The fertilization rate test results of the blank control group, TSA control group and 3-TYP group are as follows Figure 3 As shown;

[0098] Depend on Figure 3 It can be seen that the fertilization rates of the TSA control group and the 3-TYP group were higher than those of the blank control group, and that of the 3-TYP group was higher than that of the TSA group. This indicates that adding the protein deacetylase inhibitor 3-TYP to semen cryoprotectant and semen cryoprotectant can improve the fertilization ability of frozen-thawed sperm.

[0099] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the above embodiments, ordinary technicians in the relevant field should understand that the specific implementation methods of the present invention can still be modified or replaced by equivalents. Any modification or equivalent replacement that does not depart from the spirit and scope of the present invention should be covered within the scope of protection of the claims of the present invention.

Claims

1. Application of protein deacetylase inhibitor 3-TYP in ultra-low temperature cryopreservation of poultry semen.

2. The use of the protein deacetylase inhibitor 3-TYP in ultra-low temperature cryopreservation of poultry semen according to claim 1, characterized in that: The application of the protein deacetylase inhibitor 3-TYP in the ultra-low temperature cryopreservation of poultry semen specifically comprises: adding the protein deacetylase inhibitor 3-TYP into semen freezing diluent and semen freezing protection liquid.

3. The use of the protein deacetylase inhibitor 3-TYP in ultra-low temperature cryopreservation of poultry semen according to claim 1, characterized in that: The protein deacetylase inhibitor 3-TYP can be used in combination with other cryoprotectant agents.

Citation Information

Patent Citations

  • Improved organ protection, preservation and recovery

    CN103493799A

  • Application of protein deacetylase inhibitor NAM in ultralow-temperature cryopreservation of poultry semen

    CN119699307A

  • N-Phenyl Benzamide Derivatives as Sirtuin Modulators

    US20090163476A1

  • Compositions for cryopreservation and methods of use thereof

    US20190201381A1

Cited By

  • Application of protein deacetylase inhibitor NRD167 in ultralow-temperature cryopreservation of poultry semen

    CN119744838A

  • Application of protein deacetylase inhibitor NRD167 in ultra-low temperature cryopreservation of poultry semen

    CN119744838B